DE VEGA CORTAU?AS MED EXH C12 DIYODOHIDROXIQUINOLEINA-FURAZOLIDONA-HOMATROPINA Contenido: 90 mg de Ustekinumab

Description

Contenido: 90 mg de Ustekinumab

PRINCIPIO ACTIVO: CLOBETASOL 0

Tratamiento de linfoma de células del manto

Frasco ámpula con 50 mL de solución inyectable (500 mg de ácido tióctico)

Vigilar signos de reacciones de hipersensibilidad

DE VEGA CORTAU?AS MED EXH C12 DIYODOHIDROXIQUINOLEINA-FURAZOLIDONA-HOMATROPINA Contenido: 90 mg de Ustekinumab

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy